返回ChemicalBook首页>CAS数据库列表>23307-72-4

23307-72-4

中文名称 磺胺氯吡嗪鈉
英文名称 sodium N-(6-chloropyrazinyl)sulphanilamidate
CAS 23307-72-4
分子式 C10H10ClN4NaO2S
分子量 308.72
MOL 文件 23307-72-4.mol
更新日期 2025/12/06 14:53:28
23307-72-4 结构式 23307-72-4 结构式

基本信息

中文别名
4-氨基-N-(6-氯-2-吡嗪基)苯磺酰胺钠盐
((4-氨基苯基)磺酰基)(6-氯吡嗪-2-基)酰胺钠
英文别名
Sulfaclozine (sodium salt)
Sulfaclozine sodium monohydrate
sodium N-(6-chloropyrazinyl)sulphanilamidate
Sodium ((4-aminophenyl)sulfonyl)(6-chloropyrazin-2-yl)amide
4-Amino-N-(6-chloro-2-pyrazinyl)benzenesulfonamide sodium salt
所属类别
分析化学:离子色谱试剂

物理化学性质

储存条件Keep in dark place,Inert atmosphere,2-8°C
溶解度DMF: 1 mg/ml; DMSO: 1 mg/ml; PBS (pH 7.2): 1 mg/ml
形态neat
颜色Light yellow to yellow

安全数据

WGK Germany3

常见问题列表

生物活性
Sulfaclozine sodium (Sulfachloropyrazine sodium) 是一种有效的磺酰胺衍生物,具有抗菌和抗球虫作用。Sulfaclozine sodium 通常用于各种家禽疾病(尤其是结肠杆菌病,禽霍乱和球虫病)的相关研究。
靶点

Bacterial; Parasite

体外研究

The elimination of Sulfaclozine in the three systems: UV/TiO 2 , UV/K 2 S 2 O 8 , and UV/TiO 2 /K 2 S 2 O 8 . Sulfaclozine is weakly adsorbed on the surface of TiO 2 at pH 7 (< 5%) but efficiently eliminated with the following three systems: UV/TiO 2 , UV/K 2 S 2 O 8 , and UV/TiO 2 /K 2 S 2 O 8 in ultra pure water. Moreover, 12 of Sulfaclozine by-products are identified and reaction pathways show that, in addition of OH and SO 4 •− radicals, the conduction-band electrons are responsible for the formation of some main by-products either directly or by the formation of superoxide radicals.

体内研究

Sulfaclozine (60 mg/kg; intravenous injection or oral administration; male broiler chickens) can be used primarily for the treatment of parasitic and microbial infections of the digestive tract rather than for the treatment of systemic infections.

Animal Model: 14 male broiler chickens (30-day-old)
Dosage: 60 mg/kg
Administration: Intravenous injection or oral administration (Pharmacokinetic Analysis)
Result: Serum drug concentrations at 0.083, 0.50, 2, 6, 24 and 72h were determined to be 99.62, 83.50, 72.68, 58.43, 38.66 and 13.14 μg/mL, respectively, by intravenous injection. By oral administration were determined as 4.33, 7.95, 16.46, 22.88, 16.03 and 5.74 μg/mL, respectively.
"23307-72-4" 相关产品信息
73231-34-2 101831-37-2